Overview
The DIA Pharmacovigilance (PV) Strategies Workshop is a unique platform for PV professionals to interact, share experiences, and learn in a neutral environment. Engage in rich discussions with a diverse group of stakeholders, including regulators, industry, trade associations, patients, academia, and solution providers.
This workshop format offers thought-provoking dialogue that explores a range of topics, from ethics to emerging technologies. Key regulators in the pharmacovigilance space, including EMA and National Competent Authorities, will be represented in these discussions.
Discover how to apply the latest cutting-edge strategies and solutions in your organisation and daily work to boost your PV performance. Real-world-application, accessibility to experts, and a mix of representatives make this workshop an invaluable opportunity for any PV professional.
You can also expect:
Think Tank Session: As part of the agenda, you will have the chance to join a collaborative workshop on the topic of 'Building Pharmacovigilance Regulations/GVP'. Using a design-thinking framework, you will collaborate in multi-stakeholder teams to build a revolutionary vision for GVP and develop concrete next steps.
Featured
Want to learn more about Pharmacovigilance Strategies Workshop? You've come to the right site!
Program Committee
-
Francoise Sillan, MD EU1 UK QPPV
Ipsen, France -
Wendy Huisman, PharmD Director
Vigifit, Netherlands -
Shahin Kauser Leading Senior Scientific Assessor
MHRA, United Kingdom -
Maarten Lagendijk, MSc Deputy EU QPPV
MSD, Netherlands -
Willemijn van der Spuij, MSc Executive Director Europe WorldWide Patient Safety
Switzerland -
James Whitehead, MBA, MSc Senior Director, Device & Digital Safety
AstraZeneca, United Kingdom -
Esther De Vries, MS, MSc Assessor Pharmacovigilance
MEB, Netherlands
Have an account?